Lauren Biscaldi, MS, Managing Editor

Results of a study at the Veterans Health Administration found that feedback and education led to better medication outcomes for patients.

Study results are especially important for women, who are more likely to experience heart failure with mildly reduced or preserved ejection fraction.

Researchers evaluated the efficacy of a self-managed intervention vs enhanced usual care.

A PDUFA date for acoramidis has been set for November 29, 2024.

Continued methylphenidate or atomoxetine use may be safe, but additional studies are needed.

After shared decision making with their community pharmacist, patients were more likely to receive an RSV vaccine.

As “therapeutic orphans,” pregnant women and their health care providers must balance the benefits of treatment with the risk of fetal harm.

High copayments can be a structural barrier to medication therapy adherence.

The drug is also approved to treat schizophrenia and bipolar depression.

With nearly 7 million women living in a health care desert, pharmacists can provide crucial reproductive care services.

The NCPA 2024 Annual Convention and Expo runs through October 29, 2024, in Columbus, Ohio.

Before marketing your pharmacy’s immunizations services, check out these takeaways from NCPA.

PBM reform legislation has progressed further in Congress than ever before.

A second immunization session focused on updates in meningococcal disease, HPV, and Mpox.

The digest was released at the NCPA 2024 Annual Convention and Expo.

Making the store’s front end a priority can increase revenue opportunities and boost pharmacy profit.

The Drug Enforcement Administration gives controlled substance licenses, and can just as easily take them away.

The first of a 2-part presentation focused on vaccines for COVID-19, flu, RSV, and pneumococcal disease.

The new recommendations suggest vaccination at age 50, rather than age 65.

Abrysvo is the only RSV vaccine approved for use in this age group.

Results of the SOUL clinical trial will be presented at a scientific meeting in 2025.

Opioid use disorder risk was higher in a cohort of patients with chronic pain without disability.

Multimodal analgesia provides more effective pain management—and leads to a decrease in opioid use.

Vaccination against HPV can prevent thousands of cases of cancer each year.

Research is limited on the effectiveness and efficacy of this class of medications.

Patients with chronic migraine can frequently overuse acute medications, leading to medication overuse headaches.

Three RSV vaccines are currently FDA approved for use in adults aged 60 or older.

Cases of meningococcal disease currently exceed prepandemic levels.